key: cord-0784077-1jbagimb
authors: Abrams, Mark P.; Coromilas, Ellie J.; Wan, Elaine Y.; Rubin, Geoffrey A.; Garan, Hasan; Dizon, Jose M.
title: Malignant Ventricular Arrhythmias in Patients with Severe Acute Respiratory Distress Syndrome Due to COVID-19 without Significant Structural Heart Disease
date: 2020-08-25
journal: HeartRhythm Case Rep
DOI: 10.1016/j.hrcr.2020.08.017
sha: 97dc34b53535b9334caf19eaddf670ad8ce9df99
doc_id: 784077
cord_uid: 1jbagimb

nan

Since December 2019, the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) 38 has resulted in a pandemic of novel coronavirus infections. Although 39 predominantly a respiratory illness that can cause acute respiratory distress syndrome (ARDS), 40 data suggest cardiovascular involvement contributes significantly to the disease's mortality. Data While significant structural heart disease is a risk factor for ventricular arrhythmias, their 51 occurrence in the absence of major cardiac abnormalities requires a full examination of cardiac 52 and non-cardiac causes. Furthermore, since respiratory failure is typically associated with 53 pulseless electrical activity (PEA) and asystole rather than ventricular tachycardia (VT) or 54 ventricular fibrillation (VF), the etiology of malignant ventricular arrhythmias in patients without 55 heart disease and a primarily acute pulmonary disease process requires further investigation. 3 A 39 year old man with hypertension, non-insulin dependent diabetes, and epilepsy presented 90 with fever, cough, and dyspnea. Upon presentation, his temperature was 39.4C with an oxygen 91 saturation of 85% on room air that increased to 95% on 6 liters of oxygen delivered by nasal We present 5 patients among whom cardiac risk factors were common including obesity, 169 hypertension, and diabetes. All patients were male, which has been associated with increased 170 mortality in Only one (5) had a history of coronary artery disease, but none had a 171 history of heart failure, LV dysfunction, or ECG evidence of infarct. However, all had VT or VF, which was refractory to defibrillation and amiodarone in 3 (1, 2, and 5). While these patients 

Cardiovascular Implications of Fatal Outcomes of Patients With 245 Coronavirus Disease 2019 (COVID-19)

Patterns of Care, and Mortality for Patients 247 With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

Mechanism of death: there's more to it than sudden cardiac arrest

Incidence and prognosis of sustained arrhythmias in 252 critically ill patients

Community-acquired pneumonia requiring admission to an 254 intensive care unit: a descriptive study

In-hospital cardiac arrest outcomes among patients with COVID-19 256 pneumonia in Wuhan, China. Resuscitation. 2020

COVID-19 and Thrombotic or Thromboembolic 258 Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Evaluation of a ventilation strategy to prevent 261 barotrauma in patients at high risk for acute respiratory distress syndrome

Limited Ventilation Strategy Group

Electrophysiology of Hypokalemia and Hyperkalemia. Circ 264 Arrhythm Electrophysiol

Phase 2 reentry as a trigger to initiate ventricular fibrillation during 266 early acute myocardial ischemia

Clinical predictors of mortality due to COVID-19 based 268 on an analysis of data of 150 patients from Wuhan, China

Coronavirus Disease 2019 (COVID-19) and Cardiovascular 270 Disease

• Myocardial injury is defined by elevated serum troponin levels and is associated with increased mortality in COVID-19 infection. • Current practice recommendations for management of acute respiratory distress syndrome, a common process in severely infected COVID-19 patients encourages a strategy of lung protective ventilation. This includes low tidal volume ventilation to prevent ventilator associated barotrauma and oxygen toxicity, permissive hypercapnia/acidosis, and lower oxygenation goals.• A lung protective ventilation strategy in COVID-19 patients where renal failure, metabolic acidosis, and hyperkalemia are common may predispose certain patients with myocardial injury to malignant ventricular arrhythmias.